Navigation Links
New OxyContin® Has Lower Street Price Than Old Crushable Formulation
Date:11/15/2011

JACKSONVILLE, Fla., Nov. 15, 2011 /PRNewswire/ -- The new harder to crush version of OxyContin® has a lower street price than the original, according to research revealed at a conference of law enforcement officers today. Last week, the Centers for Disease Control and Prevention (CDC) announced that every day 100 people die from drug overdoses in the United States, 74% involving prescription opioid pain relievers. A new formulation of the opioid pain reliever OxyContin was launched in 2010, accompanied by hope that it would deter drug abuse, injection and overdose. A year later, researchers have shown that the new formulation sells for 28% less than the original OxyContin on the black market, using street price data from the RADARS® System StreetRx.com, an online crowdsourcing website recently featured in Fortune magazine. The price per milligram of the new difficult to crush OxyContin is $0.56, compared to $0.78 for the original during the first half of this year. Similar results were seen in a survey of law enforcement officers from the RADARS System Drug Diversion program.

The results were presented by Nabarun Dasgupta at the 22nd Annual Educational Training Conference of the National Association of Drug Diversion Investigators (NADDI), in Jacksonville, Florida. Establsihed in 1989, NADDI is a unique organization whose hundreds of members are responsible for investigating and prosecuting pharmaceutical drug diversion throughout the United States. The audience, made up mostly of law enforcement officials, reacted positively to the street price data on OxyContin and confirmed that the new formulation was not worth as much as the original. "As the pharmaceutical industry tries to engineer new drugs that are harder to crush, snort or inject, the unregulated free market of diverted prescription drugs can reveal how effective these efforts are," says Dasgupta. "In the end, these products will be judged by the human suffering they cause or prevent. Black market street prices can tell us that story ahead of time."

The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System (www.radars.org) is a surveillance system run by Denver Health for measuring rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. StreetRx.com and Drug Diversion Program are components of the RADARS System. The Drug Diversion Program is composed of hundreds of prescription drug diversion investigators or regulatory agencies who are surveyed quarterly and asked to report street prices for prescription drugs. The study is conducted by Dr. Hilary Surratt of Nova Southeastern University, Fort Lauderdale, Florida. StreetRx.com is a website that assembles and organizes online crowd sourced information about the black-market price of prescription drugs. The street market for prescription medications—such as Vicodin®, Adderall®, and fentanyl—comprises a vast underground economy that is little studied and poorly understood. Launched by public-health researchers at Epidemico, Boston, Massachusetts, StreetRx closes this knowledge gap, providing an extensive, searchable database of the latest street price data.

In the analysis, data collected during the first six months of 2011 from StreetRx.com and Drug Diversion were compared. The small difference between the price estimates was expected, as individual drug users have a stronger self-interest to bargain for lower prices than undercover law enforcement agents who are trying to make a buy.

Twitter: @StreetRx
Web: www.streetrx.com


'/>"/>
SOURCE StreetRx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Confirms OxyContin® Patent Challenge
2. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
8. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
9. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
10. Kmart Lowers Flu Shot Price to $10
11. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):